Orthocell Ltd (OCC)

Currency in AUD
0.720
-0.005(-0.69%)
Delayed Data·
Advertisement
OCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7200.738
52 wk Range
0.7001.600
Key Statistics
Bid/Ask
0.715 / 0.725
Prev. Close
0.725
Open
0.73
Day's Range
0.72-0.738
52 wk Range
0.7-1.6
Volume
105.62K
Average Volume (3m)
386.95K
1-Year Change
-42.6295%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OCC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.250
Upside
+73.61%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Orthocell Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.250
(+73.61% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
03/06/2026
EPS / Forecast
-- / --
Revenue / Forecast
3.2M / --
EPS Revisions
Last 90 days

Compare OCC to Peers and Sector

Metrics to compare
OCC
Peers
Sector
Relationship
P/E Ratio
−15.8x−5.6x−0.4x
PEG Ratio
0.07−0.010.00
Price/Book
4.8x2.9x2.6x
Price / LTM Sales
21.2x12.6x3.0x
Upside (Analyst Target)
71.2%104.4%53.6%
Fair Value Upside
Unlock9.0%7.6%Unlock

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental applications; and Remplir, a collagen scaffold used in peripheral nerve repair. The company also develops Collagen Medical Device platform products for nerve, tendon, and ligament repair; and Tendon Cell Therapy for rotator cuff and lateral epicondyle indications. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.02M0.74%1.47M
Other Institutional Investors
9.50M3.49%6.88M
Public Companies & Retail Investors
260.73M95.77%189.03M
Total
272.25M100.00%197.38M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Wyllie Group Pty Ltd1.70%4,614,9923,346
The University of Western Australia0.87%2,360,9731,712

FAQ

What Is the Orthocell Ltd (Sydney: OCC) Share Price Today?

The Orthocell Ltd stock price today is 0.720 AUD.

What Stock Exchange Does Orthocell Ltd (OCC) Trade On?

Orthocell Ltd is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for Orthocell Ltd?

The stock symbol (also called a 'ticker') for Orthocell Ltd is "OCC."

What Is the Current Orthocell Ltd Market Capitalisation?

As of today, Orthocell Ltd (Sydney: OCC) market cap is 197.380M AUD.

What Is Orthocell Ltd's (OCC) Earnings Per Share (TTM)?

The Orthocell Ltd EPS is currently -0.052 (Trailing Twelve Months).

When Is the Next Orthocell Ltd Earnings Date?

Orthocell Ltd's next earnings report will be released on 28/08/2026.

Is OCC a Buy or Sell From a Technical Analyst Perspective?

Based on today's Orthocell Ltd moving averages and other technical indicators, the daily buy/sell signal for OCC stock is Strong Sell.

How Many Times Has Orthocell Ltd Stock Split?

Orthocell Ltd has split 0 times. (See the OCC stock split history page for full effective split date and price information.)

What is the current trading status of Orthocell Ltd (Sydney: OCC)?

As of 01/07/2026, Orthocell Ltd (OCC) is trading at a share price of 0.720 AUD, with a previous close of 0.725 AUD. The stock has fluctuated within a day range of 0.720 AUD to 0.738 AUD, while its 52-week range spans from 0.700 AUD to 1.600 AUD.

What Is Orthocell Ltd (OCC) Price Target According to Analysts?

The average 12-month price target for Orthocell Ltd is 1.250 AUD, with a high estimate of 1.26 AUD and a low estimate of 1.24 AUD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.61% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.